Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An "Old" Biomarker That Can Learn New Tricks: Prognostic Role of Free Psa Ratio at Biochemical Recurrence After Radical Treatments for Prostate Cancer

NCT03927287 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT03927287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03927287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An "Old" Biomarker That Can Learn New Tricks: Prognostic Role of Free Psa Ratio at Biochemical Recurrence After Radical Treatments for Prostate Cancer
Lead sponsor
Rabin Medical Center
Phase
Observational
Overall status
Completed
Start date
January 1, 2018
Completion date
April 10, 2019
Enrollment
822 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

castration-resistant prostate cancer, death, metastasis